Intralipid/Heparin ( DrugBank: Heparin )

---

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
316	カルニチン回路異常症	1
317	三頭酵素欠損症	1

316. カルニチン回路異常症

---

臨床試験数 : 4 /  薬物数 : 10 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 11

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02517307 (ClinicalTrials.gov)	February 2016	2/7/2015	Fatty Acid Oxidation Defects and Insulin Sensitivity	Role of Fatty Acid Oxidation Defects in Insulin Sensitivity	Very Long-chain Acyl-CoA Dehydrogenase Deficiency;Trifunctional Protein Deficiency;Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency;Medium-chain Acyl-CoA Dehydrogenase Deficiency;Normal Volunteers;Carnitine Palmitoyltransferase II Deficiency, Myopathic	Drug: Intralipid/Heparin;Drug: Glycerol/Saline;Drug: Hyperinsulinemic euglycemic clamp	Oregon Health and Science University	NULL	Completed	18 Years	N/A	All	52	N/A	United States

317. 三頭酵素欠損症

---

臨床試験数 : 3 /  薬物数 : 8 - (DrugBank : 4) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02517307 (ClinicalTrials.gov)	February 2016	2/7/2015	Fatty Acid Oxidation Defects and Insulin Sensitivity	Role of Fatty Acid Oxidation Defects in Insulin Sensitivity	Very Long-chain Acyl-CoA Dehydrogenase Deficiency;Trifunctional Protein Deficiency;Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency;Medium-chain Acyl-CoA Dehydrogenase Deficiency;Normal Volunteers;Carnitine Palmitoyltransferase II Deficiency, Myopathic	Drug: Intralipid/Heparin;Drug: Glycerol/Saline;Drug: Hyperinsulinemic euglycemic clamp	Oregon Health and Science University	NULL	Completed	18 Years	N/A	All	52	N/A	United States